-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Maintains Neutral on Vera Therapeutics, Lowers Price Target to $29

Benzinga·11/06/2026 16:48:21
Listen to the news
Wedbush analyst Laura Chico maintains Vera Therapeutics (NASDAQ:VERA) with a Neutral and lowers the price target from $34 to $29.